Ultrasound Guided Trigeminal Nerve Block for Typical or Atypical Facial Pain
NCT ID: NCT02024724
Last Updated: 2017-07-11
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE4
60 participants
INTERVENTIONAL
2013-11-30
2017-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Local anesthetic and steroids have been successfully used for diagnostic and or therapeutic nerve pain with great success. Steroids can be short or long acting in duration with varying side effects. If there exists a difference in duration of action, using the longer acting drug will provide a greater period of symptom relief for the patient and may allow the patient to undergo fewer interventional procedures.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
A Phase IIa Withdrawal Study of CNV1014802 in Patients With Trigeminal Neuralgia
NCT01540630
Nasal Carbon Dioxide for the Symptomatic Treatment of Classical Trigeminal Neuralgia
NCT02473016
Randomized Study of L-Baclofen in Patients With Refractory Trigeminal Neuralgia
NCT00004431
Multimodal Nerve Block and Pulse Radiofrequency for Acute Herpes Zoster Pain
NCT06798662
Trigeminal Neuralgia Electrophysiology
NCT05269472
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Dexamethasone
4 mg of Dexamethasone and 4 mL of 0.25% bupivacaine
Bupivacaine
4 mL of 0.25% bupivacaine
Dexamethasone
4 mg of Dexamethasone
Triamcinolone
40 mg of Triamcinolone and 4 mL of 0.25% bupivacaine
Bupivacaine
4 mL of 0.25% bupivacaine
Triamcinolone
40 mg of Triamcinolone
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Bupivacaine
4 mL of 0.25% bupivacaine
Triamcinolone
40 mg of Triamcinolone
Dexamethasone
4 mg of Dexamethasone
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
75 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Northwestern University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Antoun Nader
Professor of Anesthesiology
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Antoun Nader, MD
Role: PRINCIPAL_INVESTIGATOR
Northwestern University Feinberg School of Medicine
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Anesthesiology Pain Medcine Center
Chicago, Illinois, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
STU00083918
Identifier Type: OTHER
Identifier Source: secondary_id
STU00083918
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.